DVT Prophylaxis Never Utilized Which Results in Deadly Pulmonary Embolism

ByMichael Talve, CEO


Updated onDecember 16, 2016

DVT Prophylaxis Never Utilized Which Results in Deadly Pulmonary Embolism

This case involves a 39-year-old severely obese man who presented to the hospital with severe right flank pain. Upon admission, the patient had a CT scan which showed a hematoma on the right side. The hospital staff elected to not put him on anti-coagulants for prophylaxis; due to a possible ongoing bleed even though the patient was bed ridden and not improving. One week into his hospital stay, the patient experienced severe shortness of breath and leg swelling. The only treatment he received was Albuterol. The patient was not given compression stockings nor was he considered for more advanced DVT prophylaxis such as an IVC filter. A pulmonologist was not called in for a consult until patient’s condition deteriorated to the point of intubation. The patient was eventually diagnosed with a pulmonary embolism and died shortly thereafter.

Question(s) For Expert Witness

1. What precautions should have been taken with this type of patient?

Expert Witness Response E-000565

inline imageA patient with a hematoma would not be a candidate initially for anti-coagulation. Once there was no further evidence of bleeding, and ideally, the cause of the hematoma understood, prophylactic dosages of subcutaneous heparin or low-molecular weight heparin could be administered to prevent deep venous thrombi (DVT) in a bedridden patient at risk for this common disorder. In a patient with increased risk of DVT who has a relative contraindication for anti-coagulation, sequential compression devices (SCD's) could have been used to decrease his risk of DVT and subsequent PE. This device could have been used upon his admission to the hospital. Once he became short of breath and developed leg swelling, pulmonary embolism should have been considered and a diagnostic study performed. PE is a major killer in this country and most deaths occur without an antemortem diagnosis and the opportunity for effective treatment.

About the author

Michael Talve, CEO

Michael Talve, CEO

Michael Talve stands at the forefront of legal innovation as the CEO and Managing Director of Expert Institute. Under his leadership, the Expert Institute has established itself as a vital player in the legal technology arena, revolutionizing how lawyers connect with world-class experts and access advanced legal technology. Michael's role involves not only steering the company's strategic direction but also ensuring the delivery of unparalleled intelligence and cutting-edge solutions to legal professionals. His work at Expert Institute has been instrumental in enhancing the capabilities of attorneys in case preparation and execution, making a significant impact on the legal industry's approach to expert consultation and technological integration. Michael's vision and execution have positioned the Expert Institute as a key facilitator in the intersection of law and technology.

Find an expert witness near you

What State is your case in?

What party are you representing?

background image

Subscribe to our newsletter

Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.